Advertisement

Skin Cutaneous Toxicities

  • Deborah Tomlinson
  • Nan D. McIntosh
Part of the Pediatric Oncology book series (PEDIATRICO, volume 22)

Keywords

Hair Loss Graft Versus Host Disease Allogeneic Hematopoietic Stem Cell Transplantation Acute Graft Versus Host Disease Chronic Graft Versus Host Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alley E, Green R, Schuchter L (2002) Cutaneous toxicities of cancer therapy. Current Opinions in Oncology 14:212–216Google Scholar
  2. Batchelor D (2001) Hair and cancer chemotherapy: consequence and nursing care-a literature study. European Journal of Cancer Care10(3):147–163PubMedGoogle Scholar
  3. Billingham RE (1966) The biology of graft-vs-host reactions. In: The Harvey Lectures. New York: Academic Press, 62:21Google Scholar
  4. Boot-Vickers M, Eaton K (1999) Skin care for patients receiving radiotherapy. Professional Nurse 14(10):706–708Google Scholar
  5. Botchkarev VA (2003) Molecular mechanisms of chemotherapy-induced hair loss. Journal of Investigative Dermatology Symposium Proceedings 8(1):72–75Google Scholar
  6. Botchkarev VA, Komarova EA, Siebenhaar F, Botchkarev NV, Kmarov PG, Maurer M, Gilchrest BA, Gudkov AV (2000) p53 is essential for chemotherapy-induced hair loss. Cancer Research 60(18):5002–5006PubMedGoogle Scholar
  7. Campbell J, Lane C (1996) Developing a skin-care protocol in radiotherapy. Professional Nurse 12(2):105–8Google Scholar
  8. Cetkovska P, Pizinger K, Cetkovsky P (2002) High-dose cytosine arabinoside-induced cutaneous reactions. Journal of the European Academy of Dermatology and Venerology 16(5):481–485Google Scholar
  9. Chou RH, Wong GB, Kramer JH, Wara DW, Matthay KK, Crittenden MR, Swift PS, Cowan MJ, Wara WM (1996) Toxicities of total-body irradiation for pediatric bone marrow transplantation. International Journal of radiation Oncology, Biology and Physics 34(4):843–851Google Scholar
  10. Davis KJ, Cokkinides VE, Weinstock MA, O’Connell MC, Wingo PA (2002) Summer sunburn and sun exposure among US youths ages 11 to 18: national prevalence and associated factors. Pediatrics 110(1 part 1):27–35PubMedGoogle Scholar
  11. Ferrara JL, Levy R, Chao NJ (1999) Pathophysiologic mechanisms of acute graft-vs-host disease. Biology of Blood and Marrow Transplant 5(6):347–356Google Scholar
  12. Goker H, Ibrahim CH, Chao NJ (2001) Acute graft-vs-host disease: pathophysiology and management. Experimental Hematology 29(3):259–277PubMedGoogle Scholar
  13. Hicks J, Bartholomew J, Ward-Smith P, Hutto CJ (2003) Quality of life among childhood cancer patients. Journal of Pediatric Oncology Nursing 20(4):192–200PubMedGoogle Scholar
  14. Hopkins M, Pownall J, Scott L (1999) Acute and subacute side effects of radiotherapy. In Gibson F, Evans M (eds) Paediatric Oncology: Acute Nursing care. London: WhurrGoogle Scholar
  15. Horsley L, Charlton A, Waterman C (2003) Reducing skin cancer mortality by 2010: lessons from children’s sunburn. British Journal of Dermatology 148(3):607PubMedGoogle Scholar
  16. Hughes BR, Cunliffe WJ, Bailey CC (1989) Excess benign melanocytic naevi after chemotherapy for malignancy in childhood. British Medical Journal 299(6691):88–91PubMedGoogle Scholar
  17. Indinnimeo M, Cicchini C, Kanakaki S, Larcinese A, Mingazzini PL (2003) Chemotherapy-induced radiation recall myositis. Oncology Reports 10(5):1401–1403PubMedGoogle Scholar
  18. Jacobsohn DA, Vogelsang GB (2002) Novel Pharmacotherapeutic Approaches to Prevention and Treatment of GVHD. Drugs 62(6):879–889.PubMedGoogle Scholar
  19. Katsimbri P, Bamias A, Pavlidis N (2000) Prevention of chemotherapy-induced alopecia using an effective scalp cooling system. European Journal of Cancer 36(6):766–771PubMedGoogle Scholar
  20. Macduff C, Mackenzie T, Hutcheson A, Melville L, Archibald H (2003) The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel. European Journal of Cancer Care 12(2):154–161PubMedGoogle Scholar
  21. McGrath P (2002) Beginning treatment for childhood acute lymphoblastic: insights from the parents’ perspective. Oncology Nurses Forum 29(6):988–996Google Scholar
  22. Peters C, Minkov M, Gadner H, Klingebiel T, Vossen J, Locatelli F, Cornish J, Ortega J, Bekasi A, Souillet G, Stary J, Niethammer D; European Group for Blood and Marrow Transplantation (EBMT) Working Party Paediatric Diseases; International BFM Study Group-Subcommittee Bone Marrow Transplantation (IBFM-SG) (2000) Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children. Bone Marrow Transplant 26(4):405–411PubMedGoogle Scholar
  23. Porock D, Nikoletti S, Kristjanson L (1999) Management of radiation skin reactions: literature review and clinical application. Plastic Surgery Nursing 19(4):185–192Google Scholar
  24. Richards C, Wujcik D (1992) Cutaneous toxicity associated with high-dose cytosine arabinoside. Oncology Nurses Forum 19(8):1191–1195.Google Scholar
  25. Ridderheim M, Bjurberg M, Gustavsson A (2003) Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients. Support Care Cancer 11(6):371–377PubMedGoogle Scholar
  26. Shere Y, Shoenfield Y (1998) Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant 22(9):873–881PubMedGoogle Scholar
  27. Sullivan KM, Deeg HJ, Sanders J, Klosterman A, Amos D, Shulman H, Sale G, Martin P, Witherspoon R, Appelbaum F, et al. (1986) Hyperacute graft-versus-host disease in patients not given immunosuppression after allogeneic marrow transplantation. Blood 67(4):1172–1175PubMedGoogle Scholar
  28. Tabbara IA, Zimmerman K, Morgan C, Nahleh Z. Allogeneic hematopoietic stem cell transplantation (2002) Allogeneic Hematopoietic Stem Cell Transplantation: complications and results. Archives of Internal Medicine 162(14):1558–1566PubMedGoogle Scholar
  29. Whitlock JA, Wells RJ, Hord JD, Janco RL, Greer JP, Gay JC, Edwards JR, McCurley TL, Lukens JN (1997) High-dose cytosine arabinoside and etoposide: an effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia. Leukemia 11(2):185–189PubMedGoogle Scholar
  30. Wu LM, Chin CC (2003) Factors related to satisfaction with body image in children undergoing chemotherapy. Kaohsiung Journal of Medical Science 19(5):217–224Google Scholar
  31. Yeo W, Johnson PJ (2000) Radiation-recall skin disorders associated with the use of antineoplastic drugs: pathogenesis, prevalence, and management. American Journal of Clinical Dermatology 1(2):113–116PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Deborah Tomlinson
  • Nan D. McIntosh

There are no affiliations available

Personalised recommendations